A new study investigated whether patients with a rare condition in which major internal organs are reversed from their normal ...

AstraZeneca has been cleared to include cardiovascular and kidney outcomes data on the label of its type 2 diabetes ... able to reduce hospitalisations for heart failure and cardiovascular death ...